Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trikafta in Cystic Fibrosis Subjects 2 Through 5 Years of Age
NCT04537793Phase 3Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Nov 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of elexacaftor + tezacaftor + ivacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Nov 2020; status: completed.
02
Drugs
elexacaftor + tezacaftor + ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04537793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04537793.